Amplification and expression of cyclin D genes (CCND 1, CCND2 and CCND3) in human malignant gliomas

Brain Pathology

Volumn 9, Issue 3, 1999, Pages 435-442

  Büschiges, Rainer ^a   Weber, Ruthild G ^b   Actor, Bertrand ^b   Lichter, Peter ^b   Collins, V Peter ^c   Reifenberger, Guido ^a,d  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; REGULATOR PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DELETION MUTANT; GENE AMPLIFICATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; RETINOBLASTOMA;

EID: 0032977544     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1999.tb00532.x     Document Type: Article

References (28)

1. Bögler O, Su Huang HJ, Kleihues P, Cavenee WK (1995) The p53 gene and its role in human brain tumors. Glia 15: 308-327
2. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
3. Cavalla P, Dutto A, Piva R, Richiardi P, Grosso R, Schiffer D (1998) Cyclin D1 expression in gliomas. Acta Neuropathol. (Berl.) 95: 131-135
4. Chakrabarty A, Bridges LR, Gray S (1996) Cyclin D1 in astrocytic tumours: an immunohistochemical study. Neuropathol. Appl. Neurobiol. 22: 311-316
5. Cobbers JM, Wolter M, Reifenberger J, Ring GU, Jessen F, An HX, Niederacher D, Schmidt EE, Ichimura K, Floeth F, Kirsch L, Borchard F, Louis DN, Collins VP, Reifenberger G (1998) Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol. 8: 263-276
6. Collins VP, James CD (1993) Gene and chromosomal alterations associated with the development of human gliomas. FASEB J. 7: 926-930
7. Costello JF, Plass C, Arap W, Chapman VM, Held WA, Berger MS, Su Huang HJ, Cavenee WK (1997) Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57: 1250-1254
8. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia. Mol. Pathol. 51: 1-7
9. Du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry, 19: 27-41
10. He J, Olson JJ, James CD (1995) Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res. 55: 4833-4836
11. Hosokawa Y, Arnold A (1996) Cyclin D1/PRAD1 as a central target in oncogenesis. J. Lab. Clin. Med. 127: 246-252
12. Ichimura K, Schmidt EE, Goike HM, Collins VP (1996) Human glioblastomas with no alterations of the CDKN2A (p16INK4a, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13: 1065-1072
13. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT (1992) Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13: 565-574
14. Kleihues P, Burger PC, Scheithauer B (1993) Histological typing of tumours of the central nervous system, pp. 16-19, Springer-Verlag, Berlin
15. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y (1998) DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol. 152: 1107-1123
16. Lantos PL, Vandenberg SR, Kleihues P (1996) Tumours of the nervous system. In: Greenfield's Neuropathology, Graham Dl, Lantos PL (eds.)., 6th Edition, Vol 2, pp. 583-879, Edward Arnold: London
17. Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 53: 1986-1989
18. Lichter P, Bentz M, Joos S (1995) Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and com-parative genomic hybridization. Methods Enzymol. 254: 334-359
19. Nagane M, Huang HJ, Cavenee WK (1997) Advances in the molecular genetics of gliomas. Curr. Opin. Oncol. 9: 215-222
20. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, Collins VP (1996) Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res. 56: 5141-5145
21. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994) CDKN2A (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54: 6321-6324
22. Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol. 144: 1203-1218
23. Sherr CJ (1995) D-type cyclins. Trends Biochem. Sci. 20: 187-190
24. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384: 470-474
25. Telenius H, Carter NP, Bebb CE, Nordenskjöld M, Ponder BAJ, Tunnacliffe A (1992) Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer. Genomics 13: 718-725
26. Weber RG, Sommer C, Albert FK, Kiessling M, Cremer T (1996) Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybrization. Lab. Invest. 74: 108-119
27. Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstraß J, Reifenberger G, Kiessling M, Cremer T (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13: 983-994
28. Werner CA, Döhner H, Joos S, Trumper LH, Baudis M, Earth TF, Ott G, Möller P, Lichter P, Bentz M (1997) High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am. J. Pathol. 151: 335-342